Our Firm is already representing clients in the federal Biomet hip replacement litigation, and continues to receive inquiries from Biomet M2a hip recipients.
New York, New York (PRWEB) May 26, 2013
The federal litigation established for Biomet hip lawsuits continues to move forward in U.S. District Court, Northern District of Indiana, Bernstein Liebhard LLP reports. According to the Court’s website, the litigation’s next Case Management Conference has been scheduled for June 17th. All of the lawsuits pending in the Biomet hip replacement litigation allege the metal-on-metal design of the Biomet M2a Magnum hip can generate high levels of metal ions, leading to metallosis in the surrounding tissue and early failure of the device. (In re: Biomet M2a Magnum Hip Implant Products Liability Litigation – MDL No. 2391)
“Our Firm is already representing clients in the federal Biomet hip replacement litigation, and continues to receive inquiries from Biomet M2a hip recipients who have allegedly suffered serious and debilitating complications related to the metal-on-metal device. We are pleased to see this proceeding moving forward,” says Bernstein Liebhard LLP, a nationwide law firm representing the victims of defective drugs and medical devices. The Firm continues to offer free Biomet hip lawsuit evaluations to individuals allegedly injured by the Biomet M2a hip.
Biomet Hip Lawsuits
Biomet M2a Magnum Hip Replacements are metal-on-metal hip implants, which consist of a ball and cup made from a chromium-cobalt alloy. As of March 2013, court documents indicated that more than 140 Biomet hip lawsuits were pending in the federal Biomet hip replacement litigation. All federally-filed Biomet hip lawsuits were ordered transferred to the Northern District of Indiana in October 2012, in anticipation of a large number of claims.
This past January, the U.S. Food & Drug Administration (FDA) warned that metal debris shed as metal-on-metal hip components wear may accumulate to dangerous levels in the body. This occurrence can result in bone and/or soft tissue damage in the area surrounding the implant and joint, leading to adverse local tissue reactions, premature device failure, and even additional symptoms or illnesses elsewhere in the body. Among other things, the FDA cautioned doctors to consider metal ion testing if patients are experiencing symptoms of hip implant failure. According to the January announcement, the FDA is considering implementing new regulations for metal-on-metal hip implants that would make the devices ineligible for 510(k) clearances, which allowed such implants to come to market without human clinical trials.*
Alleged victims of Biomet hip replacement problems, including metallosis, hip implant failure, and other serious complications may be entitled to compensation for their medical bills, lost wages, pain and suffering, and other damages. A wealth of information about Biomet hip lawsuits is available at Bernstein Liebhard’s website. For additional information, please contact one of our attorneys today by calling 800-511-5092.
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past 10 consecutive years.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
ATTORNEY ADVERTISING. © 2013 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Felecia L. Stern, Esq.
Bernstein Liebhard LLP